Double Chin Treatments & Fat Reduction

double chin treatments, double chin removal, double chin reduction
double chin treatments, double chin removal, double chin reduction

Double Chin Treatments & Fat Reduction

Are you struggling with unwanted fullness under your chin, commonly known as a double chin? Pure Rejuvenation Anti Aging & Laser Clinic offers a state-of-the-art solution with Belkyra, also known as Kybella. As the first non-surgical treatment approved by both Health Canada and the FDA, Belkyra is specifically designed to target and reduce submental fullness, making it an ideal choice for those seeking effective double chin treatments.

Double chins are a common condition that can occur due to natural aging, health issues, and natural aging. BELKYRA™ is the first and only FDA and Health Canada approved non-surgical injectable for adults reducing moderate to severe fat deposits under the chin. BELKYRA™ is made of a substance that is naturally found in the body called deoxycholic acid. This naturally occurring compound is responsible for dissolving fat deposits and helping the body absorb them, for permanent correction, further preventing the storage and accumulation of fat cells under the chin.

Belkyra is an excellent option for both men and women who want to reduce or eliminate a double chin without undergoing surgery. Whether your double chin is due to aging, genetics, or weight gain, this treatment offers a non-invasive solution with lasting results. If you’re searching for double chin treatments that are both safe and effective, Belkyra may be the right choice for you.

The effectiveness of Belkyra as a double chin treatment lies in its active ingredient, deoxycholic acid. This naturally-occurring molecule helps break down and absorb dietary fat. When injected into the fat beneath your chin, Belkyra destroys fat cells, leading to a noticeable reduction in fullness. This targeted approach makes Belkyra one of the most reliable double chin treatments available today.

Each Belkyra session at Pure Rejuvenation Anti Aging & Laser Clinic takes approximately 30 minutes. During the treatment, your practitioner will mark the area under your chin with a grid to ensure precise targeting. Multiple small injections are administered to evenly distribute the product, resulting in uniform fat resorption. This meticulous process ensures that your double chin treatment is as effective as possible.

The number of Belkyra treatments required varies from patient to patient. Typically, most individuals achieve their desired results after 2 to 3 treatments, spaced at least four weeks apart. Our experts at Pure Rejuvenation Anti Aging & Laser Clinic will create a customized plan to meet your specific needs, ensuring that your double chin treatment is both efficient and effective.

Post-treatment, you may experience some swelling, bruising, or redness under your chin. These side effects are generally mild, and downtime is typically limited to 1-3 days. Most patients begin to see improvements within 4-6 weeks after their first treatment. For optimal results, 2 to 3 follow-up treatments may be necessary. Once the fat cells are destroyed with Belkyra, they are gone permanently, making it one of the most effective double chin treatments for long-lasting results.

One of the standout benefits of Belkyra as a double chin treatment is the permanence of the results. Once fat cells are destroyed, they can no longer store or accumulate fat, provided you maintain a stable weight. This means that with Belkyra, your double chin treatment results can last indefinitely.

The cost of Belkyra treatments at Pure Rejuvenation Anti Aging & Laser Clinic varies depending on the amount of fat to be removed. Typically, two vials are required per session, with an average cost of $650-$750 per vial. Our team will assess your needs and provide a detailed cost estimate during your consultation.

Belkyra
BELKYRA® is a registered trademark of Kythera Biopharmaceuticals, Inc., an Allergan affiliate.

Belkyra® is a registered trademark of Allergan Sales, LLC, an AbbVie company, used under license by Allergan Inc.